Nenad Grmuša

Chief Executive Officer at DEM Bio

Nenad Grmuša joined DEM Bio as Chief Executive Officer in September 2022. Before joining DEM Bio, Mr. Grmuša led the R&D strategy and external innovation group at Takeda. Prior to joining Takeda, Mr. Grmusa spent 10 years at Millennium Pharmaceuticals, Inc. in various financial planning and analysis positions with increasing responsibilities. While he was at Millennium, Mr. Grmuša worked directly with R&D leaders and the management team of Millennium Pharmaceuticals on pipeline investment management and strategic corporate planning. Prior to Millennium, he spent 3 years consulting with Boston Biomedical Consultants.